# Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections

> **NCT02665351** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 16 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Peramivir

## Key facts

- **NCT ID:** NCT02665351
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02665351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02665351, "Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02665351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*